Search results
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
Zacks via Yahoo Finance· 4 days agoIts earnings are anticipated to improve 7.3% over the next five years. The company delivered a...
FDA Accepts Professor Niazi's Petition to Allow Interchangeable Status to Biosimilars without...
KTBS Shreveport· 12 hours agoAccording to Pharmaceutical Scientist, Inc., biosimilars are copies of biological drugs introduced after the expiry of the patents or exclusivity of new biological drugs as ...
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
Zacks via Yahoo Finance· 20 hours agoThe Zacks Consensus Estimate has increased $0.25 to $17.13 per share. VRTX boasts an average...
Sun Pharma’s Phase I GL0034 study shows weight loss efficacy and lipid reduction
Clinical Trials Arena via Yahoo Finance· 17 hours agoDanish company Novo Nordisk recently reported DKr61bn ($8.7bn) in sales from...loss, Zealand Pharma...
Chapel Hill pharma fights back against fentanyl crisis - Triangle Business Journal
The Business Journals· 21 hours agoA pharmaceutical company in Chapel Hill is advancing its efforts to address the fentanyl crisis....
Alnylam Shares Soar After Drug Meets Goal in Heart Disease Trial
Bloomberg· 22 hours agoHave a confidential tip for our reporters? Alnylam Pharmaceuticals Inc. shares soared after its drug...
Cheaper Versions of Popular New Weight-Loss Drugs Are Being Developed
Scientific American· 4 days agoBlockbuster weight-loss drugs such as Wegovy could soon become a lot cheaper — and reach more people...
SkyCell nabs $59M more for its greener smart pharma transport containers
TechCrunch· 2 hours agoTybourne Capital Management and CCI are together putting in $59 million, on top of the $57 million...
Alnylam’s heart disease drug meets main goal in late-stage study
WHTC 1450 Holland· 22 hours ago(Reuters) -Alnylam Pharmaceuticals said on Monday that its drug vutrisiran met the main goal in a late-stage study testing it as a treatment for a type ...
Alnylam hits ‘home run’ in clinical trial, shares rise 35% - Boston Business Journal
The Business Journals· 15 hours agoShares of Alnylam Pharmaceuticals Inc. shot up Monday after the company reported a successful...